This was following the IHC data, where α-SMA expression in cancerous tissue was markedly higher than that in paired normal tissue, with α-SMA-positive PROX1-expressing cancer cells exhibiting significantly higher invasive potential than those with null α-SMA expression. This evidence concerns the gene ACTA1 and cancer.